phone+44 203 371 1100

Ligand Pharmaceuticals Incorporated

Credit Sector:- Health Care

Country:- United States

Bond Document:- https://www.bondpdf.com

In order to view the complete data, please login here

List of Corporate Actions

Announcement Date CA Type CA Impact CA Event ISIN
11-Feb-2020 Propose Asset Acquisition - - US00214WAE12
Ligand Pharmaceuticals Incorporated today announced that it has intends to acquire core assets of Icagen, Inc. s North Carolina operations.
06-Apr-2020 Offer Repurchase - - US53220KAE82
Ligand Pharmaceuticals Incorporated today announced that it intends to repurchase any or all of the outstanding USD, 0.75% Fixed bond due 15-May-2023.
11-Oct-2020 Propose Sell Stock Target Name Vernalis (R&D) Limited US00214WAE12
Ligand Pharmaceuticals Incorporated announced today that it intends to sell Entire Issued Share Capital of Vernalis (R&D) Limited.
23-Mar-2022 Propose Merger Target Name Avista Public Acquisition Corp. II US00214WAE12
Ligand Pharmaceuticals Incorporated announced that it intends to merge with Avista Public Acquisition Corp. II as OmniAb, Inc.
01-Nov-2022 Spin Off Spin-Off Name Ligand Pharmaceuticals Incorporated US00214WAE12
OmniAb, Inc. today announced the completion of the expected tax-free spin-off from Ligand Pharmaceuticals Incorporated.

View more details

FactEntry

All of the financial data available on this page is sourced from FactEntry.